Natriumchloride Baxter (Sodium Chloride)

Sodium chloride, the active ingredient in Natriumchloride Baxter, is an electrolyte solution presented as an injection solution for intravenous use. It restores sodium and chloride concentrations and expands extracellular fluid volume, providing fluid and electrolyte replacement for patients with hypovolemia or hyponatremia.

GNH USA supplies Natriumchloride Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Natriumchloride Baxter is an intravenous electrolyte solution used to correct fluid and electrolyte disturbances in several clinical settings.

- Fluid and electrolyte replacement: restores plasma volume and normal sodium/chloride balance. - Hypovolemia: expands intravascular volume to improve circulatory stability. - Hyponatremia: raises serum sodium concentration to safe levels.

Adverse reactions may occur with any intravenous solution. Monitoring and appropriate administration techniques help minimize risk.

Common Side Effects: - Injection site pain: discomfort at the infusion site. - Phlebitis: inflammation of the vein used for infusion. - Hypernatremia: elevated serum sodium levels. - Hyperchloremia: increased serum chloride levels. - Fluid overload: excess extracellular fluid accumulation. - Electrolyte imbalance: disturbances in other electrolytes.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate treatment. - Severe hypervolemia: dangerous fluid overload leading to pulmonary edema. - Metabolic acidosis: significant pH disturbance. - Cardiac arrhythmia: abnormal heart rhythm due to electrolyte shifts. - Contamination‑related sepsis: infection from non‑sterile product.

Safe use of Natriumchloride Baxter requires assessment of patient status and careful monitoring.

- Assess fluid status: evaluate volume needs before infusion. - Monitor serum electrolytes: check sodium and chloride levels regularly. - Adjust infusion rate in cardiac failure: avoid rapid volume expansion. - Use caution in renal impairment: reduced excretion may increase risk of overload. - Avoid rapid infusion in neonates: slower rates reduce complications. - Store at ambient temperature: keep in original packaging, protect from light, and do not freeze.

Sodium chloride infusion can interact with other therapies that affect fluid and electrolyte balance.

Major Interactions (Avoid): - Hypertonic saline solutions: combined use may cause severe hypernatremia. - Large-volume potassium chloride infusions: risk of electrolyte overload. - High‑dose mannitol: may exacerbate fluid shifts.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase sodium loss, requiring adjustment. - ACE inhibitors: can affect renal handling of sodium. - NSAIDs: may impair renal function and alter fluid balance. - Corticosteroids: can influence electrolyte retention. - Vasopressors: may require careful volume management.